bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2023,
Номер
unknown
Опубликована: Дек. 20, 2023
Abstract
Niemann-Pick
type
C
disease
(NPCD)
is
a
lysosomal
disorder
whith
patients
presenting
highly
variable
onset,
neurovisceral
symptoms
and
life
spans
due
to
defective
lipid
homeostasis.
At
present,
therapeutic
options
are
limited
palliative
disease-modifying
drugs,
there
continued
need
for
new
approaches.
Here,
we
explored
bromodomain
extraterminal
(BET)
proteins
as
drug
target
NPCD
using
patient-derived
fibroblasts.
Treatment
of
cells
with
JQ1,
prototype
BET
inhibitor,
enhanced
the
level
NPC1
protein
increased
its
presence
in
lysosomes,
diminished
expansion
cholesterol
accumulation
induced
extracellular
release
components
time-
dose-dependent
manner.
The
reversal
pathologic
changes
an
established
cell
model
suggest
inhibition
approach
NPCD.
Biomedicines,
Год журнала:
2023,
Номер
11(10), С. 2793 - 2793
Опубликована: Окт. 14, 2023
Many
potential
immune
therapeutic
targets
are
similarly
affected
in
adult-onset
neurodegenerative
diseases,
such
as
Alzheimer's
(AD)
disease,
Parkinson's
disease
(PD),
amyotrophic
lateral
sclerosis
(ALS),
and
frontotemporal
dementia
(FTD),
well
a
seemingly
distinct
Niemann-Pick
type
C
with
primarily
juvenile
onset.
This
strongly
argues
for
an
overlap
pathogenic
mechanisms.
The
commonly
researched
include
various
cell
subsets,
microglia,
peripheral
macrophages,
regulatory
T
cells
(Tregs);
the
complement
system;
other
soluble
factors.
In
this
review,
we
compare
these
diseases
from
clinical
point
of
view
highlight
common
pathways
mechanisms
protein
aggregation,
neurodegeneration,
and/or
neuroinflammation
that
could
potentially
lead
to
shared
treatment
strategies
overlapping
dysfunctions
diseases.
These
approaches
but
not
limited
immunisation,
cascade
blockade,
microbiome
regulation,
inhibition
signal
transduction,
Treg
boosting,
stem
transplantation.
Cell Communication and Signaling,
Год журнала:
2023,
Номер
21(1)
Опубликована: Дек. 14, 2023
Abstract
Viruses
communicate
with
their
hosts
through
interactions
proteins,
lipids,
and
carbohydrate
moieties
on
the
plasma
membrane
(PM),
often
resulting
in
viral
absorption
via
receptor-mediated
endocytosis.
Many
viruses
cannot
multiply
unless
host’s
cholesterol
level
remains
steady.
The
large
endo/lysosomal
protein
(MP)
Niemann-Pick
C1
(NPC1),
which
is
involved
cellular
transport,
a
crucial
intracellular
receptor
for
infection.
NPC1
ubiquitous
housekeeping
essential
controlled
efflux
from
lysosomes.
Its
human
absence
results
type
C
disease,
deadly
lysosomal
storage
disorder.
an
host
component
filovirus
entrance,
infection,
pathogenesis.
For
NPC1’s
function
unnecessary.
Furthermore,
blocking
limits
entry
replication
of
African
swine
fever
virus
by
disrupting
homeostasis.
Cell
entrance
quasi-enveloped
variants
hepatitis
A
E
has
also
been
linked
to
NPC1.
By
controlling
levels,
necessary
effective
release
reovirus
cores
into
cytoplasm.
Drugs
that
limit
activity
are
against
several
viruses,
including
SARS-CoV
Type
I
Feline
Coronavirus
(F-CoV).
These
findings
reveal
as
potential
therapeutic
target
treating
illnesses
demonstrate
its
significance
infections.
This
article
provides
synopsis
infections
review
inhibitors
may
be
used
counteract
Graphical
Many
of
the
potential
immune
therapeutic
targets
are
similarly
affected
in
adult-onset
neurodegenerative
diseases
such
as
Alzheimer’s
(AD)
disease,
Parkinson’s
disease
(PD),
amyotrophic
lateral
sclerosis
(ALS),
and
frontotemporal
dementia
(FTD),
but
also
a
seemingly
distinct
Niemann-Pick
type
C
with
primarily
juvenile-onset.
This
strongly
argues
for
an
overlap
pathogenic
mechanisms.
The
commonly
researched
include
various
cell
subsets
microglia,
peripheral
macrophages,
or
regulatory
T
cells
(Tregs),
complement
system,
other
soluble
factors.
In
this
review,
we
will
compare
these
from
clinical
point
view
out
common
pathways
mechanisms
protein
aggregation,
neurodegeneration
and/or
neuroinflammation
that
could
potentially
lead
to
shared
treatment
strategies.
We
describe
approaches
treating
dysfunctions
disorders,
moving
immunization
microbiome
regulation
stem
treatment.
Inborn
errors
of
lysosomal
function
often
provoke
disorders
presenting
highly
variable
onset,
diverse
visceral,
neurologic
and
psychiatric
symptoms
reduced
life
spans.
A
prime
example
is
Niemann-Pick
type
C
disease
(NPCD).
At
present,
therapeutic
options
are
limited
to
palliative
care
disease-modifying
drugs,
there
a
need
for
new
treatments.
Here,
we
explored
bromodomain
extra-terminal
domain
(BET)
proteins
as
drug
target
NPCD
using
patient-derived
skin
fibroblasts.
Treatment
cells
with
JQ1,
prototype
BET
protein
inhibitor,
enhanced
the
level
NPC1
protein,
diminished
expansion
cholesterol
accumulation,
induced
extracellular
release
components
in
dose-
time-dependent
manner.
The
effect
JQ1
on
levels
was
largely
independent
from
patient
line
tested,
but
extent
reduction
varied
line-dependent
Lastly,
accumulation
by
inhibition
activity
histone
deacetylases,
respectively.
Taken
together,
our
results
provide
further
evidence
epigenetic
regulation
cellular
homeostasis.
Pharmacologic
should
be
candidate
approach
tool
understand
basic
mechanisms
lipid
metabolism.
American Journal of Medical Genetics Part A,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 3, 2025
ABSTRACT
An
illustration
of
the
importance
manual
data
review
for
identifying
rare
intronic
variants
adjacent
to
homopolymers
is
presented
here.
A
14‐year‐old
male
with
Niemann‐Pick
Type
C
disease
confirmed
biochemically
was
only
found
have
a
heterozygous
pathogenic
variant
by
molecular
analysis.
Next
Generation
Sequencing
(NGS)
identified
c.709C>T;
p.Pro237Ser
variant,
which
likely
not
reported
initially
because
it
consistently
classified
as
benign
or
benign.
association
c.709C>T
second
NPC1
(c.1947
+
5G>C)
leading
use
cryptic
splice
donor
site
has
been
before.
Further
evaluation
Sanger
sequencing
detected
c.1947
5G>C
causative
in
this
patient.
Detection
allelic
change
autosomal
recessive
inborn
errors
metabolism
and
other
genetic
disorders
vital
establishing
diagnosis,
initiating
new
therapies,
testing
at
risk
family
members.
The
case
here
illustrates
that
may
be
readily
current
short‐read
NGS
technologies
due
downstream
should
evaluated
regularly,
especially
presence
another
variant.
IntechOpen eBooks,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 3, 2025
This
chapter
provides
a
comprehensive
examination
of
how
next-generation
sequencing
(NGS)
technologies
are
transforming
prenatal
and
neonatal
care,
particularly
in
the
diagnosis
lysosomal
diseases
(LDs).
These
rare,
inherited
conditions
caused
by
defects
metabolism.
If
not
detected
treated
early,
they
can
lead
to
significant
disabilities
reduced
life
expectancy.
The
specifically
focuses
on
use
NGS
diagnose
screen
sphingolipidoses
(SLDs)
mucopolysaccharidoses
(MPSs).
It
covers
molecular
pathogenesis,
classification,
main
symptomatology
diseases.
reviews
progress
made
identifying
genes
associated
with
SLDs
MPSs
cataloging
clinically
relevant
genetic
variants.
Additionally,
it
highlights
growing
adoption
for
screening
institutions
such
as
academic
research
centers,
private
healthcare
providers,
government
health
agencies.
also
discusses
challenges
implementation,
regulation,
outlines
future
directions
its
application
medicine.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(8), С. 4217 - 4217
Опубликована: Апрель 11, 2024
Niemann-Pick
disease
type
C1
(NPC1)
is
a
lysosomal
disorder
due
to
impaired
intracellular
cholesterol
transport
out
of
the
endolysosomal
compartment.
Marked
heterogeneity
has
been
observed
in
individuals
with
same
NPC1
genotype,
thus
suggesting
significant
effect
modifier
genes.
Prior
work
demonstrated
that
decreased
SOAT1
activity
severity
an
mouse
model.
Thus,
we
hypothesized
polymorphism
associated
expression
might
influence
phenotype.
Phenotyping
and
genomic
sequencing
117
was
performed
as
part
Natural
History
trial.
included
determination
burden.
Significant
clinical
present
homozygous
for
NPC1I1061T
variant
siblings.
Analysis
polymorphism,
rs1044925
(A>C),
showed
association
C-allele
earlier
age
neurological
onset.
The
may
be
higher
Annualized
Severity
Index
Score
well
increased
frequency
liver
seizures.
A
appears
genetic
This
finding
consistent
prior
data
showing
phenotypic
Npc1-/-:Soat1-/-
mice
supports
efforts
investigate
potential
inhibitors
therapy
NPC1.
Frontiers in Neurology,
Год журнала:
2025,
Номер
16
Опубликована: Фев. 26, 2025
Niemann-Pick
type
C
(NPC)
disease
is
a
rare
neurodegenerative
disorder
with
wide
spectrum
of
clinical
manifestations
and
genetic
variability.
This
cross-sectional
study
aimed
to
comprehensively
describe
the
neuropsychological
impact
NPC
investigate
its
correlation
specific
genotypes.
Eight
patients
from
six
unrelated
families
were
included
in
this
study.
Their
age
at
symptom
onset
ranged
between
2
16
years,
all
presenting
ataxia,
dysarthria,
cognitive
impairment.
Following
initiation
miglustat
treatment,
five
showed
decrease
Scale
for
Assessment
Rating
Ataxia
(SARA)
score,
whereas
three
demonstrated
subsequent
increases.
Five
underwent
brain
magnetic
resonance
imaging
scans,
revealing
white
matter
abnormalities
and/or
volumetric
reduction
cases.
Despite
small
sample
size,
overall
performance
cohort
was
significantly
below
average.
The
Family
Environment
highlighted
positive
structural
patterns,
particularly
regarding
Personal
Growth
System
Maintenance.
Genetic
analysis
identified
mutations
NPC1
gene
that
correlated
severity
impairments
outcomes.
indicated
consistent
association
behavioral
impairments,
correlating
variants.
Notably,
one
subgroup
higher
prevalence
psychotic
symptoms,
suggesting
potential
link